• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同等念珠菌评分:一种源自当前指南的 ECMM 评分,用于衡量念珠菌血症临床管理质量。

EQUAL Candida Score: An ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia Management.

机构信息

Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.

Department I of Internal Medicine, ECMM Center of Excellence for Medical Mycology, German Centre for Infection Research, partner site Bonn-Cologne (DZIF), University of Cologne, Cologne, Germany.

出版信息

Mycoses. 2018 May;61(5):326-330. doi: 10.1111/myc.12746. Epub 2018 Feb 20.

DOI:10.1111/myc.12746
PMID:29325218
Abstract

Candida species frequently cause blood stream infections and are reported to be the third to tenth most commonly isolated pathogens. Guidelines and standardised treatment algorithms provided by professional organisations aim to facilitate decision-making regarding diagnosis, management and treatment of candidaemia. In routine clinical practise, however, it may be challenging to comply with these guidelines. The reasons include lack of familiarity or feasibility to adherence, but also their length and complexity. There is no tool to measure guideline adherence currently. To provide such a tool, we reviewed the current guidelines provided by the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) and by the Infectious Diseases Society of America (IDSA), and selected the strongest recommendations for management quality as the bases for our scoring tool. Factors incorporated were diagnostic (blood cultures, echocardiography, ophthalmoscopy, species identification) and follow-up procedures (repeat blood cultures until negative result) as well as key treatment parameters (echinocandin treatment, step down to fluconazole depending on susceptibility result, CVC removal). The EQUAL Candida Score weighs and aggregates factors recommended for the ideal management of candidaemia and provides a tool for antifungal stewardship as well as for measuring guideline adherence.

摘要

念珠菌属物种常引起血流感染,据报道是第三至第十种最常分离的病原体。专业组织提供的指南和标准化治疗算法旨在促进关于念珠菌血症的诊断、管理和治疗的决策。然而,在常规临床实践中,可能难以遵守这些指南。原因包括不熟悉或难以遵守,以及其长度和复杂性。目前没有衡量指南依从性的工具。为了提供这样的工具,我们回顾了欧洲临床微生物学和传染病学会 (ESCMID) 和美国传染病学会 (IDSA) 提供的现行指南,并选择了管理质量最强的建议作为我们评分工具的基础。纳入的因素包括诊断(血培养、超声心动图、眼底检查、菌种鉴定)和随访程序(重复血培养直至阴性结果)以及关键治疗参数(棘白菌素治疗、根据药敏结果降阶梯至氟康唑、CVC 移除)。EQUAL Candida 评分权衡和汇总了念珠菌血症理想管理推荐的因素,为抗真菌药物管理以及衡量指南依从性提供了工具。

相似文献

1
EQUAL Candida Score: An ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia Management.同等念珠菌评分:一种源自当前指南的 ECMM 评分,用于衡量念珠菌血症临床管理质量。
Mycoses. 2018 May;61(5):326-330. doi: 10.1111/myc.12746. Epub 2018 Feb 20.
2
Candida and candidaemia. Susceptibility and epidemiology.念珠菌与念珠菌血症。药敏性与流行病学。
Dan Med J. 2013 Nov;60(11):B4698.
3
Management of candidaemia with reference to the European confederation of medical mycology quality indicators.参考欧洲医学真菌学联合会质量指标管理念珠菌血症。
Infect Dis (Lond). 2019 Jul;51(7):527-533. doi: 10.1080/23744235.2019.1606436. Epub 2019 May 11.
4
Analyzing candidemia guideline adherence identifies opportunities for antifungal stewardship.分析念珠菌血症指南的依从性可确定抗真菌药物管理的机会。
Eur J Clin Microbiol Infect Dis. 2018 Aug;37(8):1563-1571. doi: 10.1007/s10096-018-3285-8. Epub 2018 Jun 13.
5
Candidaemia in the non-neutropenic patient: a critique of the guidelines.非中性粒细胞减少患者的念珠菌血症:对指南的批判。
Int J Antimicrob Agents. 2013 Oct;42(4):294-300. doi: 10.1016/j.ijantimicag.2013.06.005. Epub 2013 Sep 7.
6
Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: a retrospective observational cohort study of the Mycoses Study Group (MSG-12).棘白菌素类药物与氟康唑治疗成人近平滑念珠菌血症的疗效比较:真菌病研究组(MSG-12)的一项回顾性观察队列研究
J Antimicrob Chemother. 2016 Dec;71(12):3536-3539. doi: 10.1093/jac/dkw305. Epub 2016 Jul 27.
7
European confederation of medical mycology quality of clinical candidaemia management score: A review of the points based best practice recommendations.欧洲医学真菌学联合会临床念珠菌血症管理质量评分:基于要点的最佳实践建议综述
Mycoses. 2021 Feb;64(2):123-131. doi: 10.1111/myc.13196. Epub 2020 Oct 28.
8
Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes.基于药敏试验结果评估念珠菌血症患者的抗真菌治疗:对抗菌药物管理计划的启示。
J Antimicrob Chemother. 2011 Sep;66(9):2146-51. doi: 10.1093/jac/dkr244. Epub 2011 Jun 23.
9
Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study.欧洲念珠菌血症患者的指南依从性和生存情况:来自 ECMM Candida III 多国欧洲观察性队列研究的结果。
Lancet Infect Dis. 2023 Jun;23(6):751-761. doi: 10.1016/S1473-3099(22)00872-6. Epub 2023 Feb 15.
10
Our 2014 approach to candidaemia.我们2014年治疗念珠菌血症的方法。
Mycoses. 2014 Oct;57(10):581-3. doi: 10.1111/myc.12207. Epub 2014 May 26.

引用本文的文献

1
Physician's Compliance to Clinical Practice Guidelines and Outcomes of Patients With Invasive Candidiasis in a University Hospital in Thailand.泰国一家大学医院内科医生对临床实践指南的遵循情况及侵袭性念珠菌病患者的治疗结果
Mycoses. 2025 Jul;68(7):e70094. doi: 10.1111/myc.70094.
2
The Impact of Epidemiological Trends and Guideline Adherence on Candidemia-Associated Mortality: A 14-Year Study in Northeastern Italy.流行病学趋势和指南依从性对念珠菌血症相关死亡率的影响:意大利东北部的一项14年研究
J Fungi (Basel). 2025 May 21;11(5):400. doi: 10.3390/jof11050400.
3
Tracking Candidemia Trends and Antifungal Resistance Patterns across Europe: An In-Depth Analysis of Surveillance Systems and Surveillance Studies.
追踪欧洲念珠菌血症趋势及抗真菌耐药模式:对监测系统和监测研究的深入分析
J Fungi (Basel). 2024 Sep 29;10(10):685. doi: 10.3390/jof10100685.
4
Insights from Three Pan-European Multicentre Studies on Invasive Candida Infections and Outlook to ECMM Candida IV.三项关于侵袭性念珠菌感染的泛欧多中心研究的见解及欧洲临床微生物与感染病学会念珠菌IV会议展望
Mycopathologia. 2024 Aug 1;189(4):70. doi: 10.1007/s11046-024-00871-0.
5
Combination of Systemic and Lock-Therapies with Micafungin Eradicate Catheter-Based Biofilms and Infections Caused by and in Neutropenic Rabbit Models.在中性粒细胞减少的兔模型中,米卡芬净的全身治疗与锁疗法联合使用可根除由[未提及的两种病原体]引起的基于导管的生物膜和感染。
J Fungi (Basel). 2024 Apr 17;10(4):293. doi: 10.3390/jof10040293.
6
Guideline Adherence and Outcomes of Patients with Candidemia in Brazil.巴西念珠菌血症患者的指南遵循情况及治疗结果
J Fungi (Basel). 2024 Apr 12;10(4):282. doi: 10.3390/jof10040282.
7
Invasive candidiasis.侵袭性念珠菌病。
Nat Rev Dis Primers. 2024 Mar 21;10(1):20. doi: 10.1038/s41572-024-00503-3.
8
The Cologne ECMM Excellence Center: A Two-Year Analysis of External Consultation Service for Invasive Fungal Infections.科隆欧洲临床微生物与感染病学会卓越中心:侵袭性真菌感染外部咨询服务的两年分析
Mycopathologia. 2024 Mar 11;189(2):25. doi: 10.1007/s11046-023-00822-1.
9
Necrotizing pancreatitis with invasive candidiasis and candidemia due to and pan-echinocandin-resistant .坏死性胰腺炎合并侵袭性念珠菌病及念珠菌血症,病因是泛棘白菌素耐药的[具体菌种未给出]。
Med Mycol Case Rep. 2024 Feb 20;43:100636. doi: 10.1016/j.mmcr.2024.100636. eCollection 2024 Mar.
10
Fungal diseases in Africa: Closing the gaps in diagnosis and treatment through implementation research and advocacy.非洲的真菌病:通过实施研究和宣传消除诊断和治疗方面的差距。
J Mycol Med. 2023 Nov;33(4):101438. doi: 10.1016/j.mycmed.2023.101438. Epub 2023 Oct 19.